iXensor Co., Ltd. (TPEX:6734)
6.81
-0.05 (-0.73%)
Apr 29, 2026, 1:46 PM CST
iXensor Revenue
In the year 2025, iXensor had annual revenue of 26.88M TWD with 38.14% growth. iXensor had revenue of 12.54M in the half year ending June 30, 2025, with 10.11% growth.
Revenue
26.88M
Revenue Growth
+38.14%
P/S Ratio
7.82
Revenue / Employee
n/a
Employees
n/a
Market Cap
210.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.88M | 7.42M | 38.14% |
| Dec 31, 2024 | 19.46M | -1.43M | -6.85% |
| Dec 31, 2023 | 20.89M | -84.35M | -80.15% |
| Dec 31, 2022 | 105.24M | 80.44M | 324.44% |
| Dec 31, 2021 | 24.79M | 8.87M | 55.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.80B |
| AViTA | 936.39M |
| Diamond Biotechnology | 698.11M |
| EPS Bio Technology | 499.70M |
| Health & Life | 398.05M |
| Radiant Innovation | 387.58M |
| Wiltrom | 311.77M |
| S&S Healthcare Holding | 204.21M |